| Literature DB >> 35886431 |
Kapil Khadka1, Kunle Adesigbin1, Jessica Beetch2, Katrin Kuhn2, Aaron Wendelboe2.
Abstract
We aimed to better understand the racially-/ethnically-specific COVID-19-related outcomes, with respect to time, to respond more effectively to emerging variants. Surveillance data from Oklahoma City-County (12 March 2020-31 May 2021) were used to summarize COVID-19 cases, hospitalizations, deaths, and COVID-19 vaccination status by racial/ethnic group and ZIP code. We estimated racially-/ethnically-specific daily hospitalization rates, the proportion of cases hospitalized, and disease odds ratios (OR) adjusting for sex, age, and the presence of at least one comorbidity. Hot spot analysis was performed using normalized values of cases, hospitalizations, and deaths generated from incidence rates per 100,000 population. During the study period, there were 103,030 confirmed cases, 3457 COVID-19-related hospitalizations, and 1500 COVID-19-related deaths. The daily 7-day average hospitalization rate for Hispanics peaked earlier than other groups and reached a maximum (3.0/100,000) in July 2020. The proportion of cases hospitalized by race/ethnicity was 6.09% among non-Hispanic Blacks, 5.48% among non-Hispanic Whites, 3.66% among Hispanics, 3.43% among American Indians, and 2.87% among Asian/Pacific Islanders. COVID-19 hot spots were identified in ZIP codes with minority communities. The Hispanic population experienced the first surge in COVID-19 cases and hospitalizations, while non-Hispanic Blacks ultimately bore the highest burden of COVID-19-related hospitalizations and deaths.Entities:
Keywords: SARS-CoV-2; public health response; public health surveillance; time-varying; vulnerability
Mesh:
Substances:
Year: 2022 PMID: 35886431 PMCID: PMC9316515 DOI: 10.3390/ijerph19148571
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Distribution of age and race/ethnicity in the United States and Oklahoma County [13].
| Demographic | U.S. | Oklahoma City–County | |||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Total | 328,239,523 | 100.0 | 956,092 | 100.0 | |
| Age (years) | |||||
| <18 | 73,039,150 | 22.3 | 244,159 | 25.5 | |
| 18–39 | 97,897,048 | 29.8 | 299,080 | 31.3 | |
| 40–49 | 40,319,374 | 12.3 | 113,794 | 11.9 | |
| 50–59 | 42,354,542 | 12.9 | 116,175 | 12.1 | |
| 60–69 | 38,026,147 | 11.6 | 98,170 | 10.3 | |
| 70–79 | 23,681,097 | 7.2 | 53,876 | 5.6 | |
| ≥80 | 12,922,165 | 3.9 | 30,838 | 3.2 | |
| Race/Ethnicity | |||||
| Non-Hispanic White | 196,789,401 | 60.0 | 566,985 | 59.3 | |
| Non-Hispanic Black | 40,596,040 | 12.4 | 121,756 | 12.7 | |
| American Indian | 2,236,348 | 0.7 | 25,474 | 2.7 | |
| Asian/Pacific Islander | 18,427,914 | 5.8 | 35,503 | 3.7 | |
| Other race | 839,270 | 0.3 | 1989 | 0.2 | |
| Two or more races | 8,303,331 | 2.5 | 53,197 | 5.6 | |
| Hispanic | 60,481,746 | 18.4 | 151,188 | 15.8 | |
Figure A1The study area of Oklahoma City–County with ZIP code boundaries.
The distribution of reported clinical characteristics by population-based race/ethnicity in Oklahoma City–County, 12 March 2020–31 May 2021. The denominator for vaccination status is the population age 5+ years; ≥1 dose refers to individuals receiving the first dose of the Pfizer and Moderna COVID-19 vaccines or a single shot of the J&J/Janssen vaccine; fully vaccinated refers to individuals fully vaccinated after receiving either both doses of the Pfizer and/or Moderna COVID-19 vaccines or a single shot of the J&J/Janssen vaccine.
| American | Asian/Pacific Islander | Non-Hispanic Black | Hispanic | Non-Hispanic White | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 25,474 | N = 35,503 | N = 121,756 | N = 151,188 | N = 566,985 | N = 900,906 | ||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | ||
| Clinical | |||||||||||||
| Case | 2447 | 9.6 | 2576 | 7.3 | 9970 | 8.2 | 13,885 | 9.2 | 42,079 | 7.4 | 70,957 | 7.9 | |
| Vaccination ≥ 1 dose | 8402 | 31.8 | 15,803 | 53.4 | 28,774 | 23.5 | 38,049 | 30.1 | 167,428 | 38.5 | 258,456 | 34.9 | |
| Age group (years) | |||||||||||||
| 5–17 | 312 | 2.1 | 902 | 17.8 | 1063 | 3.7 | 2650 | 6.5 | 5570 | 8.6 | 10,497 | 7.2 | |
| 18–35 | 2054 | 21.5 | 4970 | 53.2 | 6159 | 16.7 | 13,657 | 32.8 | 36,670 | 33.0 | 63,510 | 30.7 | |
| 36–49 | 1980 | 34.6 | 3823 | 55.8 | 6116 | 27.7 | 9952 | 41.8 | 30,982 | 38.3 | 52,853 | 38.1 | |
| 50–64 | 2317 | 46.3 | 3711 | 69.8 | 8635 | 40.2 | 8144 | 56.2 | 40,672 | 44.5 | 63,479 | 46.2 | |
| 65+ | 1739 | 52.3 | 2397 | 78.8 | 6801 | 49.4 | 3646 | 66.6 | 53,534 | 61.9 | 68,117 | 60.9 | |
| Gender | |||||||||||||
| Female | 4822 | 34.7 | 8469 | 52.9 | 16,574 | 25.7 | 20,695 | 34.0 | 90,890 | 40.7 | 141,450 | 37.3 | |
| Male | 3575 | 28.5 | 7290 | 53.7 | 12,158 | 20.9 | 17,300 | 26.4 | 76,315 | 36.1 | 116,638 | 32.3 | |
| Fully vaccinated | 7424 | 28.1 | 13,505 | 45.6 | 24,156 | 19.7 | 30,681 | 24.3 | 151,111 | 34.8 | 226,877 | 30.7 | |
| Age group (years) | |||||||||||||
| 5–17 | 109 | 2.1 | 378 | 7.5 | 337 | 1.2 | 1061 | 2.6 | 1977 | 3.0 | 3862 | 2.7 | |
| 18–35 | 1793 | 21.5 | 4369 | 46.8 | 4876 | 13.2 | 10,916 | 26.2 | 32,287 | 29.1 | 54,241 | 26.2 | |
| 36–49 | 1782 | 34.6 | 3345 | 48.8 | 5175 | 23.5 | 8255 | 34.7 | 28,429 | 35.2 | 46,986 | 33.9 | |
| 50–64 | 2112 | 46.3 | 3255 | 61.3 | 7625 | 35.5 | 7112 | 49.1 | 37,612 | 41.2 | 57,716 | 42.0 | |
| 65+ | 1628 | 52.3 | 2158 | 71.0 | 6143 | 44.6 | 3337 | 61.0 | 50,806 | 58.8 | 64,072 | 57.3 | |
| Gender | |||||||||||||
| Female | 4292 | 30.9 | 7310 | 45.7 | 14,015 | 21.7 | 16,838 | 27.7 | 82,754 | 37.0 | 125,209 | 33.0 | |
| Male | 3130 | 25.0 | 6169 | 45.4 | 10,111 | 17.4 | 13,805 | 21.1 | 68,183 | 32.3 | 101,398 | 28.0 | |
Distribution of reported demographic characteristics among reported COVID-19 cases by race/ethnicity in Oklahoma City–County, 12 March 2020–31 May 2021.
| American Indian | Asian/Pacific | Non-Hispanic Black | Hispanic | Non-Hispanic White | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | ||
| Hospitalization * | 84 | 3.4 | 74 | 2.9 | 608 | 6.1 | 509 | 5.3 | 1931 | 4.6 | 3206 | 4.5 | |
| Death ** | 28 | 1.1 | 19 | 0.7 | 187 | 1.9 | 139 | 1.0 | 946 | 2.2 | 1319 | 1.9 | |
| Sex | |||||||||||||
| Male | 1046 | 42.7 | 1222 | 47.4 | 4416 | 44.3 | 6096 | 43.9 | 19,485 | 46.3 | 32,265 | 45.5 | |
| Female | 1401 | 57.3 | 1354 | 52.6 | 5554 | 55.7 | 7789 | 56.1 | 22,594 | 53.7 | 38,692 | 54.5 | |
| Age group (years) | |||||||||||||
| 0–4 | 45 | 1.8 | 32 | 1.2 | 157 | 1.6 | 343 | 2.5 | 444 | 1.1 | 1021 | 1.4 | |
| 5–17 | 337 | 13.8 | 307 | 11.9 | 1191 | 11.9 | 2532 | 18.2 | 4227 | 10.0 | 8594 | 12.1 | |
| 18–35 | 849 | 34.7 | 894 | 34.7 | 3571 | 35.8 | 5534 | 39.9 | 12,969 | 30.8 | 23,817 | 33.6 | |
| 36–49 | 606 | 24.8 | 592 | 23.0 | 2245 | 22.5 | 3183 | 22.9 | 9095 | 21.6 | 15,721 | 22.2 | |
| 50–64 | 442 | 18.1 | 510 | 19.8 | 1801 | 18.1 | 1724 | 12.4 | 8483 | 20.2 | 12,960 | 18.3 | |
| 65+ | 168 | 6.9 | 241 | 9.4 | 1005 | 10.1 | 567 | 4.1 | 6859 | 16.3 | 8840 | 12.5 | |
| Comorbidities | |||||||||||||
| ≥1 comorbidity | 418 | 17.1 | 238 | 9.2 | 1696 | 17.0 | 1549 | 11.2 | 6853 | 16.3 | 10,754 | 15.2 | |
| Acute respiratory distress syndrome | 9 | 0.4 | 7 | 0.3 | 70 | 0.7 | 68 | 0.5 | 357 | 0.8 | 511 | 0.7 | |
| Chronic heart or circulatory disease | 167 | 6.8 | 99 | 3.8 | 828 | 8.3 | 504 | 3.6 | 3209 | 7.6 | 4807 | 6.8 | |
| Chronic liver disease | 26 | 1.1 | 15 | 0.6 | 30 | 0.3 | 50 | 0.4 | 257 | 0.6 | 378 | 0.5 | |
| Chronic lung disease | 124 | 5.1 | 62 | 2.4 | 556 | 5.6 | 347 | 2.5 | 2207 | 5.2 | 3296 | 4.6 | |
| Chronic renal failure | 23 | 0.9 | 15 | 0.6 | 151 | 1.5 | 90 | 0.6 | 482 | 1.1 | 761 | 1.0 | |
| Diabetes | 172 | 7.0 | 93 | 3.6 | 573 | 5.7 | 697 | 5.0 | 1941 | 4.6 | 3476 | 4.9 | |
| Disseminated intravascular | 9 | 0.4 | 4 | 0.2 | 43 | 0.4 | 31 | 0.2 | 186 | 0.4 | 273 | 0.4 | |
| Pneumonia | 89 | 3.6 | 45 | 1.7 | 333 | 3.3 | 306 | 2.2 | 1995 | 4.7 | 2768 | 3.9 | |
* 251 COVID-19-related hospitalizations where race/ethnicity was unknown. ** 184 COVID-19-related deaths where race/ethnicity was unknown.
Figure A2Distribution of comorbidities in COVID-19 patients by race/ethnicity.
Figure 1The 7-day average of daily hospitalization rate per 100,000 population smoothed trend lines stratified by race/ethnicity in Oklahoma City–County, 12 March 2020–31 May 2021. The vertical dashed line indicates the first date by which an Oklahoma City–County resident could have received two COVID-19 vaccine doses.
Crude and adjusted * odds ratios (95% confidence intervals) between race/ethnicity and COVID-19-related outcomes (case, hospitalization, and death).
| Race/Ethnicity | Case | Hospitalization | Death | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ORcrude | 95% CI | ORcrude | 95% CI | ORadj * | 95% CI | ORcrude | 95% CI | ORadj * | 95% CI | |
| Non-Hispanic White | Ref | - | Ref | - | Ref | - | Ref | - | Ref | - |
| American Indian | 1.3 | 1.3–1.4 | 0.6 | 0.4–0.9 | 0.8 | 0.5–1.2 | 0.48 | 0.2–1.06 | 1.3 | 0.4–3.0 |
| Asian/Pacific | 0.9 | 0.9–1.01 | 1.2 | 0.7–2.2 | 1.8 | 0.9–3.4 | 0.33 | 0.08–0.9 | 0.5 | 0.1–1.3 |
| Non-Hispanic Black | 1.1 | 1.08–1.13 | 0.9 | 0.7–1.1 | 1.4 | 1.1–1.8 | 1.01 | 0.7–1.4 | 1.7 | 1.2–2.5 |
| Hispanic | 1.3 | 1.2–1.3 | 0.6 | 0.5–0.7 | 1.2 | 0.9–1.5 | 0.33 | 0.2–0.5 | 1.2 | 0.7–1.8 |
* Adjusted for sex, age, and presence of at least one comorbidity.
Figure 2(a) Hot spots of COVID-19-related cases. (b) Hot spots of COVID-19-related hospitalizations and deaths. (c) Distribution of the Hispanic population in the Oklahoma City–County metropolitan area. (d) Distribution of the non-Hispanic Black population in the Oklahoma City–County metropolitan area.